| Literature DB >> 23455021 |
R C Vos1, J M Wit, H Pijl, E C A M Houdijk.
Abstract
BACKGROUND: Behavioral lifestyle intervention, combined with parental involvement, is preferred over standard care or self-help in childhood obesity. The short-term results of such interventions are promising, but long-term follow-up results are equivocal.Entities:
Year: 2011 PMID: 23455021 PMCID: PMC3302141 DOI: 10.1038/nutd.2011.5
Source DB: PubMed Journal: Nutr Diabetes ISSN: 2044-4052 Impact factor: 5.097
Figure 1Flow of participants through study with primary outcome measurement (BMI-SDS).
Characteristics of the family-based multidisciplinary lifestyle intervention
| Screening phase/individual counseling | During the screening phase, children and their parents were interviewed at two separate occasions and all interviewed individually by the multidisciplinary team consisting of a dietitian, a child physiotherapist, a child psychologist and a social worker. Throughout those two separate meetings, an individual advice was given by the multidisciplinary team, based on the personal situation of each participating family. |
| Individual nutritional advice | A 3-day dietary recall (1 weekend day included) was used by the dietitian to get more insight into the dietary habits of the children. Information was provided about nutrition and healthy eating behavior according to the traffic-light nutrition list.[ |
| Individual physical activity counseling | To obtain insight into the child's general physical activity behavior during the week, a physical activity questionnaire was filled out by a child physiotherapist. Children were asked how they traveled to school (by foot, by bicycle, by public transportation or by car); physical fitness classes at school, spare-time sport activities and daily computer and TV use, as well as the duration spend at all these activities were noted. The information from this questionnaire was used for advice on how to increase and optimize physical activity during everyday life, such as walking to nearby destinations and reducing sedentary activities (use of computer and TV). |
| Individual psychological counseling | By means of motivational interviewing, the child psychologist helped the children to adapting to a new lifestyle in order to reduce body weight. Before the child started with the group sessions, individual treatment goals (reduction of 10% of body weight during 3 months group sessions) were written down in a contract to avoid disappointment. |
| Children's group meetings | Most children with obesity have negative experiences with group activities. For example, they are often not included in social events or chosen last by sport activities. Therefore, during the first session, much time is spent in getting acquainted with each other. A good group bond is important for the effect of the treatment because peer support can be very helpful in the treatment of obese children. The main educational focus of the first two meetings is on nutritional information of a healthy eating pattern and the balance between energy intake and energy expenditure. During the subsequent meetings, emphasis was put in self-control techniques to cope with difficult situations (e.g., birthday parties, holidays, lunch breaks at school, being at home alone). Problem solving alternatives are debated (e.g., to avoid a situation, doing something else, participate in a situation and eat less or participate followed by extra exercise afterward). Other psycho-educational topics reviewed were self-reward (when coping well with a difficult situation) and self-regulation situations (making a plan how to integrate healthy behavior in daily living). Stimulus control was also one of the psycho-educational topics (remove unhealthy stimuli at home, encourage healthy behavior, eat at the dinner table, reduction of environmental stimuli linked to eating). Topics of the last two meetings were self-image (focus on positive things about themselves) and coping strategies on dealing with teasing. |
| Parent group meetings | Topics discussed during the parent meetings included the necessity to change their own lifestyle as well, information on healthy nutrition (product information, quantities, eating moments, eating locations) and how to help their children. Parents received advice on parenting styles (boundaries setting with regard to eating behavior, giving positive feedback). During the last meeting, a therapist discusses the role of all other family members with regard to the treatment in the family (e.g., are other family members supportive, how do they cope with the lifestyle changes). |
| Follow-up meetings | In order to maintain the newly learned behavior refresh follow-up meetings were given during the first 2 years (2–3 meetings per year). The child psychologist and the social worker organize these follow-up meetings. The topics repeated were: problem-solving techniques and relapse-prevention techniques. |
Baseline subject characteristics
| Gender (M/F) | 18/22 | 19/20 | 14/20 |
| Ethnicity (North European/other) | 14/26 | 11/28 | 18/16 |
| Puberty (Tanner ⩽1/2–5) | 5/35 | 8/31 | 7/27 |
| Age (year) | 13.3±2.0 | 13.1±1.9 | 13.2±2.4 |
| Weight (kg) | 85.7±18.4* | 85.7±18.6* | 51.7±15.1 |
| Height (cm) | 161.9±9.7 | 161.4±11.0 | 160.2±14.1 |
| BMI (kg m−2) | 32.4±4.7* | 32.5±3.9* | 19.7±3.3 |
| BMI-SDS | 4.2±0.7* | 4.3±0.6* | 0.5±1.4 |
| WC (cm) | 91.1±9.1* | 90.5±7.7* | 67.0±8.7 |
| WC-SDS | 3.7±1.0* | 3.7±0.9* | 0.3±0.9 |
| WC/Ht | 0.56±0.04* | 0.56±0.04* | 0.42±0.04 |
| VO2peak-SDS | 1.7±1.5* | 2.2±1.5* | 0.0±1.4 |
| VO2peak-SDS-kg | −3.0±1.0* | −2.8±1.0* | −0.8±1.1 |
| Glucose (mmol l−1) | 5.3±0.4 | 5.2±0.4 | 5.2±0.5 |
| Insulin (mU l−1) | 19.5±12.2* | 14.9±8.0 | 13.5±9.1 |
| HOMA-IR | 4.6±2.9 | 3.4±1.9 | 3.2±2.3 |
| HOMA-SDS | 2.1±2.3* | 1.2±1.3 | 1.0±2.1 |
| HDL (mmol l−1) | 1.1±0.3* | 1.1±0.2* | 1.3±0.2 |
| Triglycerides (mmol l−1) | 1.2±1.0* | 0.9±0.5 | 0.7±0.3 |
| Systolic blood pressure (mm Hg) | 125±13* | 126±12* | 119±9 |
| Diastolic blood pressure (mm Hg) | 65±9 | 65±7 | 67±9 |
| Adiponectin (ng ml−1) | 8.6±3.8 | 8.5±3.3 | 9.7±4.0 |
| hsCRP (mg l−1) | 2.3±2.1 | 1.8±1.5 | 0.6±0.9 |
Abbreviations: BMI, body mass index; BMI-SDS, BMI-standard deviation score; F, female; HDL, high-density lipoprotein; HOMA-IR, Homeostasis Model Assessment for insulin resistance; HOMA-SDS, standard deviation scores for HOMA-IR; hsCRP, high-sensitive C-reactive protein; M, male; VO2peak-SDS-kg, absolute oxygen uptake by body weight (ml min−1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured peak value of oxygen uptake (ml min−1), standardized for age and gender; WC, waist circumference; WC/Ht; WC and height ratio; WC-SDS, WC expressed as standard deviation score.
*Significantly different compared with normal weight control group, P<0.05, tested using ANOVA for comparing between groups.
Results are expressed as mean±s.d.
Outcome parameters at start (T1), after 3 months (T2) and after 12 months (T3) in the intervention and control groups
| BMI-SDS | 4.2 (4.0; 4.4) | 4.0 (3.7; 4.3) | 3.8 (3.4; 4.2) | 4.3 (4.1; 4.5) | 4.2 (4.0; 4.5) | 4.2 (4.0; 4.5) |
| WC-SDS | 3.7 (3.3; 4.0) | 3.4 (2.9; 3.8) | 3.0 (2.5; 3.6) | 3.7 (3.4; 4.0) | 3.7 (3.3; 4.1) | 3.5 (3.1; 4.0) |
| WC/Ht | 0.56 (0.55; 0.58) | 0.55 (0.53; 0.57) | 0.53 (0.51; 0.56) | 0.56 (0.55; 0.57) | 0.56 (0.55; 0.58) | 0.56 (0.54; 0.57) |
| VO2peak-SDS | 1.7 (1.2; 2.2) | 1.7 (1.2; 2.2) | 1.7 (1.1; 2.3) | 2.2 (1.7; 2.7) | 1.7 (1.2; 2.2) | 1.1 (0.6; 1.6) |
| VO2peak-SDS-kg | −3.0 (−3.3; −2.6) | −2.7 (−3.1; −2.3) | −2.4 (−3.0; −1.9) | −2.8 (−3.2; −2.5) | −2.9 (−3.3; −2.5) | −3.3 (−3.7; −2.9) |
| Glucose (mmol l−1) | 5.3 (5.1; 5.4) | 5.3 (5.1; 5.4) | 5.1 (5.0; 5.2) | 5.2 (5.1; 5.3) | 5.3 (5.0; 5.6) | 5.1 (5.0; 5.3) |
| Insulin (mU l−1) | 19.5 (15.6; 23.4) | 17.4 (13.1; 21.7) | 20.5 (15.2; 25.9) | 14.9 (12.3; 17.5) | 20.3 (15.5; 25.0) | 18.8 (15.6; 21.9) |
| HOMA-SDS | 2.1 (1.4; 2.9) | 1.7 (0.8; 2.5) | 2.2 (1.1; 3.3) | 1.2 (0.7; 1.6) | 2.2 (1.1; 3.4) | 1.7 (1.2; 2.3) |
| HDL (mmol l−1) | 1.1 (1.1; 1.2) | 1.1 (1.0; 1.2) | 1.1 (1.0; 1.2) | 1.1 (1.1; 1.2 | 1.2 (1.0; 1.3) | 1.1 (1.0; 1.2) |
| TG (mmol l−1) | 1.2 (0.8; 1.5) | 1.2 (0.9; 1.5) | 1.1 (0.8; 1.4) | 0.9 (0.8; 1.1) | 1.0 (0.9; 1.2) | 1.0 (0.8; 1.3) |
| SBP (mm Hg) | 125 (121; 129) | 123 (119; 127) | 118 (114; 122) | 126 (123; 131) | 125 (121; 129) | 122 (177; 128) |
| DBP (mm Hg) | 65 (62; 67) | 59 (56; 62) | 57 (54; 61) | 65 (62; 67) | 62 ( 58; 66) | 59 (56; 62) |
| Adiponectin (ng ml−1) | 8.6 (7.4; 9.8) | 9.2 (7.5; 10.9) | 9.4 (7.4; 11.4) | 8.5 (7.4; 9.6) | 9.1 (7.8; 10.5) | 8.9 (7.3; 10.5) |
| hsCRP (mg l−1) | 2.3 (1.6; 3.0) | 1.9 (1.2; 2.6) | 1.9 (1.1; 2.8) | 1.8 (1.3; 2.3) | 2.5 (1.4; 3.7) | 2.1 (1.5; 2.8) |
Abbreviations: BMI-SDS, body mass index-standard deviation score; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-SDS, standard deviation scores for Homeostasis Model Assessment for insulin resistance; SBP, systolic blood pressure; TG, triglyceride; VO2peak-SDS-kg, absolute oxygen uptake by body weight (ml min−1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured peak value of oxygen uptake (ml min−1), standardized for age and gender; WC/Ht; waist circumference and height ratio; WC-SDS, WC expressed as standard deviation score.
Results are expressed as mean (95% confidence interval).
Figure 2Physical fitness over time in the intervention and control group.
Effect of intervention on markers of adiposity, physical fitness, metabolic parameters and inflammation
| P | ||||||
|---|---|---|---|---|---|---|
| BMI-SDS | −0.4 | −0.8; 0.0 | −0.1 | −0.4; 0.3 | −0.2 (0.03; 0.42) | 0.02 |
| WC-SDS | −0.6 | −1.2; −0.0 | −0.2 | −0.7; 0.5 | −0.4 (0.04; 0.78) | 0.03 |
| WC/Ht | −0.03 | −0.06; 0.0 | −0.01 | −0.03; 0.0 | −0.02 (0.001; 0.034) | 0.03 |
| VO2peak-SDS | 0.0 | −0.7; 0.8 | −1.1 | −1.8; −0.4 | 0.7 (−1.1; −0.3) | <0.01 |
| VO2peak-SDS-kg | 0.5 | −0.0; 1.1 | −0.4 | −0.9; 0.1 | −0.7 (−1.1; −0.4) | <0.01 |
| Glucose (mmol l−1) | −0.2 | −0.3; 0.0 | −0.0 | (−0.3; 0.2) | 0.1 (−0.1; 0.3) | NS |
| Insulin (mU l−1) | 1.0 | −7.2; 5.2 | 3.9 | −1.1; 8.9 | −4.0 (−0.0; 8.0) | 0.05 |
| HOMA-SDS | 0.1 | −1.1; 1.1 | 0.6 | −0.5; 1.6 | −0.9 (0.0; 1.7) | 0.04 |
| HDL (mmol l−1) | −0.0 | −0.2; 0.1 | −0.0 | −0.2; 0.1 | −0.03 (−0.11; 0.06) | NS |
| Triglycerides (mmol l−1) | −0.1 | −0.5; 0.4 | 0.1 | −0.2; 0.4 | −0.04 (−0.3; 0.2) | NS |
| SBP (mm Hg) | −6.6 | −12.2; −1.0 | −4.3 | −10.2; 1.7 | −2.8 (−7.0; 1.5) | NS |
| DBP (mm Hg) | −7.3 | −11.5; −3.1 | −5.7 | −10.0; −1.3 | −3.2 (−6.7; 0.4) | NS |
| Adiponectin (ng ml−1) | 0.8 | −1.5; 3.0 | 0.4 | −1.4; 2.3 | 0.2 (−0.9; 1.4) | NS |
| hsCRP (mg l−1) | −0.4 | −1.4; 0.6 | −0.9 | −3.2; 1.4 | −0.8 (−1.6; 0.1) | NS |
Abbreviations: BMI-SDS, body mass index-standard deviation score; CI, confidence interval; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-SDS, standard deviation scores for Homeostasis Model Assessment for insulin resistance; hsCRP, high-sensitive C-reactive protein; NS, not significant; SBP, systolic blood pressure; VO2peak-SDS-kg, absolute oxygen uptake by body weight (ml min−1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured peak value of oxygen uptake (ml min−1), standardized for age and gender; WC/Ht; waist circumference and height ratio; WC-SDS, WC expressed as standard deviation score.
Pearson correlation coefficients of the study parameters at baseline
| BMI-SDS | — | |||||||||||||
| WC-SDS | 0.000** | — | ||||||||||||
| WC/Ht | 0.000** | 0.962** | — | |||||||||||
| VO2peak-SDS | 0.000** | 0.620** | 0.487** | — | ||||||||||
| VO2peak-SDS-kg | 0.000** | −0.737** | −0.755** | −0.061 | — | |||||||||
| Fasting glucose | 0.032 | 0.042 | 0.091 | −0.158 | −0.050* | — | ||||||||
| Fasting insulin | 0.000** | 0.331** | 0.298* | 0.040 | −0.354** | 0.304** | — | |||||||
| HOMA-SDS | 0.189*** | 0.217* | 0.239* | −0.017 | −0.356** | 0.457** | 0.433** | — | ||||||
| HDL | 0.000** | −0.466** | −0.429** | −0.326** | 0.001** | −0.048 | −0.223* | −0.243** | — | |||||
| TG | 0.006** | 0.282** | 0.249** | 0.139 | −0.021* | 0.047 | 0.366** | 0.125 | −0.370** | — | ||||
| SBP | 0.001** | 0.398** | 0.379** | 0.173 | 0.000* | 0.056 | 0.163 | 0.213* | −0.286** | 0.202* | — | |||
| DBP | −0.916 | 0.054 | 0.058 | 0.012 | −0.855 | −0.008 | 0.049 | 0.079 | −0.097 | 0.114 | 0.269** | — | ||
| Adiponectin | −0.005** | −0.272** | −0.240* | −0.118 | 0.008** | −0.049 | −0.391** | −0.297** | 0.323** | −0.110 | −0.220* | 0.001 | — | |
| hsCRP | 0.019* | −0.189* | 0.242** | 0.070 | 0.000** | 0.106 | −0.008 | −0.036 | −0.197* | −0.056 | 0.043 | 0.109 | −0.089 | — |
Abbreviations: BMI-SDS, body mass index-standard deviation score; CI, confidence interval; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-SDS, standard deviation scores for Homeostasis Model Assessment for insulin resistance; hsCRP, high-sensitive C-reactive protein; SBP, systolic blood pressure; VO2peak-SDS-kg, absolute oxygen uptake by body weight (ml min−1 per kg) and standardized it for age and gender; VO2peak-SDS, absolute measured peak value of oxygen uptake (ml min−1), standardized for age and gender; TG, triglyceride; WC/Ht; waist circumference and height ratio; WC-SDS, WC expressed as standard deviation score.
*Correlation is significant at 0.05 level (two-tailed); **correlation is significant at 0.01 level (two-tailed); ***correation is 0.189 (P=0.045).